Gryphon Bio Revenue and Competitors
Estimated Revenue & Valuation
- Gryphon Bio's estimated annual revenue is currently $930k per year.
- Gryphon Bio's estimated revenue per employee is $116,250
Employee Data
- Gryphon Bio has 8 Employees.
- Gryphon Bio grew their employee count by 60% last year.
Gryphon Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Research Scientist | Reveal Email/Phone |
Gryphon Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Gryphon Bio?
Traumatic brain injury (TBI), multiple sclerosis (MS), post-traumatic epilepsy (PTE), Alzheimer's disease and related dementias (ADRD), chronic traumatic encephalopathy (CTE), and related indications are leading causes of death and disability. Gryphon Bio is a preclinical-stage therapeutic bioconjugate company created to harness our co-founders' discovery of novel therapeutic targets and temporal biomarkers in unexpected waves of brain molecules in the blood. Mission: To develop and market the 1st therapeutic bioconjugate to accelerate brain repair and improve cognition. Vision: To pioneer therapeutic bioconjugates to improve the lives of patients with neurological or neurodegenerative diseases.
keywords:N/A
N/A
Total Funding
8
Number of Employees
$930k
Revenue (est)
60%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.6M | 8 | -27% | $27.5M |
#2 | $0.2M | 8 | -11% | $24.7M |
#3 | $0.4M | 8 | -27% | $8.5M |
#4 | $0.7M | 8 | -27% | $26.8M |
#5 | $0.1M | 8 | 14% | $11.8M |